QNCX SCHEDULE 13G/A: SEC filing

Ikarian Capital, LLC and Neil Shahrestani

Filed with the SEC on · accession 0001778253-26-000009

QNCX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Ikarian Capital, LLC and Neil Shahrestani filed an amended Schedule 13G reporting beneficial ownership of 254,058 shares (2.3%) of IRulya Therapeutics Inc. common stock as of September 30, 2026.

Summary of the filing

Ikarian Capital, LLC and Neil Shahrestani filed an amended Schedule 13G reporting beneficial ownership of 254,058 shares (2.3%) of IRulya Therapeutics Inc. common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control.

Key details

Shares beneficially owned$254K
Percent of class ownedPCT 2
Shares outstanding of issuer$10.8M
Reporting person / investment adviserIkarian Capital, LLC
IssuerIRulya Therapeutics Inc.
Record owner of sharesIkarian Healthcare Master Fund, L.P.
Sole manager of ikarian capital, llcNeil Shahrestani

✦ Ask GOAX AI about this filing — what it means for QNCX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for QNCX?

Click here

Frequently asked questions

What did QNCX file with the SEC on Nov 16, 2026?

QNCX filed a SCHEDULE 13G/A (SEC filing). Ikarian Capital, LLC and Neil Shahrestani filed an amended Schedule 13G reporting beneficial ownership of 254,058 shares (2.3%) of IRulya Therapeutics Inc. common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other QNCX SEC filings

Get alerts when QNCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days